WPI 526 (Trinessa ethinyl estradiol 0.035 mg / norgestimate 0.250 mg)
Generic Name: ethinyl estradiol/norgestimate
Pill imprint WPI 526 has been identified as Trinessa ethinyl estradiol 0.035 mg / norgestimate 0.250 mg.
TriNessa is used in the treatment of acne; birth control; abnormal uterine bleeding; ovarian cysts; endometriosis (and more), and belongs to the drug class contraceptives. Not for use in pregnancy. TriNessa ethinyl estradiol 0.035 mg / norgestimate 0.250 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for WPI 526 (Trinessa ethinyl estradiol 0.035 mg / norgestimate 0.250 mg)
- Generic Name:
- ethinyl estradiol/norgestimate
- ethinyl estradiol 0.035 mg / norgestimate 0.250 mg
- Prescription only
- Drug Class:
- Pregnancy Category:
- X - Not for use in pregnancy
- CSA Schedule:
- N - Not a controlled drug
- Watson Pharmaceuticals
More about TriNessa (ethinyl estradiol / norgestimate)
Compare with other treatments for:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...